Hap Trading, LLC Verastem, Inc. Call Options Transaction History

Hap Trading, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.33 - $10.44 $165 - $5,220	-500 Reduced 3.45%	14,000 $0
Q3 2022 Nov 14, 2022	SELL	$0.92 - $11.16 $2,668 - $32,364	-2,900 Reduced 16.67%	14,500 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.83 $4,488 - $8,052	4,400 Added 33.85%	17,400 $2,000
Q1 2022 May 12, 2022	BUY	$1.06 - $2.1 $636 - $1,260	600 Added 4.84%	13,000 $5,000
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $2,460 - $3,840	-1,200 Reduced 8.82%	12,400 $8,000
Q3 2021 Nov 10, 2021	BUY	$2.54 - $4.07 $6,604 - $10,582	2,600 Added 23.64%	13,600 $15,000
Q2 2021 Aug 11, 2021	BUY	$2.57 - $4.85 $28,270 - $53,349	11,000 New	11,000 $13,000
Q1 2021 May 14, 2021	SELL	$1.9 - $2.82 $160,170 - $237,726	-84,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $96,944 - $202,320	84,300 New	84,300 $10,000
Q3 2019 Nov 12, 2019	SELL	$1.21 - $1.59 $281,083 - $369,357	-232,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.25 - $3.14 $9,000 - $22,608	7,200 Added 3.2%	232,300 $31,000
Q1 2019 May 10, 2019	SELL	$2.79 - $4.09 $1,395 - $2,045	-500 Reduced 0.22%	225,100 $62,000
Q4 2018 Feb 12, 2019	BUY	$3.23 - $7.01 $669,902 - $1.45 Million	207,400 Added 1139.56%	225,600 $158,000
Q3 2018 Nov 09, 2018	BUY	$6.86 - $9.97 $124,852 - $181,454	18,200 New	18,200 $3,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.